Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma

Keywords: Cholangiocarcinoma, ABC294640, NOXA, MCL1, ABT-263, obatoclax

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text